Lys102

Site Information
PKKILASkYLkMLkE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 11322264
Available spectra: 2 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 )
Disease tissue studied:	colorectal cancer ( 6 , 7 ) , colorectal carcinoma ( 6 , 7 ) , lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 , 2 , 3 , 4 , 5 ) , non-small cell lung adenocarcinoma ( 1 , 2 ) , non-small cell large cell lung carcinoma ( 1 , 2 ) , non-small cell squamous cell lung carcinoma ( 5 )
Relevant cell line - cell type - tissue:	HCC78 (pulmonary) ( 1 ) , HCT116 (intestinal) ( 6 , 7 ) , lung ( 1 , 2 ) , NCI-H1299 (pulmonary) ( 2 ) , NCI-H1703 (squamous) ( 5 ) , NCI-H1734 (pulmonary) ( 2 ) , NCI-H1781 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 2 ) , NCI-H2228 (pulmonary) ( 1 ) , NCI-H3122 (pulmonary) ( 1 , 3 ) , NCI-H3255 (pulmonary) ( 4 ) , NCI-H358 (pulmonary) ( 2 ) , NCI-H460 (pulmonary) ( 2 ) , NCI-H661 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20219; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20216; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2013) CST Curation Set: 18855; Year: 2013; Biosample/Treatment: cell line, H3122/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
4	Rikova K (2012) CST Curation Set: 16031; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
5	Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
6	Moritz A (2010) CST Curation Set: 9796; Year: 2010; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
7	Moritz A (2010) CST Curation Set: 9797; Year: 2010; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
8	Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-40 19608861 Curated Info